Search
MiniMed Ord Shs (Proposed)
MMEDAdd to Watchlist
20.860USD
-0.340-1.60%
Market hours 09/23, 12:24（ET）
5.86BMarket Cap
LossP/E TTM
MiniMed Ord Shs (Proposed) (MMED) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts
Buy
4 Strong Buy
6 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
25.727USD+18.07%
MMED Analyst Recommendation Trends
In the current month, MMED has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the last month is 25.727.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
3
2
0
0
0
0
6
6
5
5
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
9
8
0
0
0
0
MMED Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Abbott Laboratories
ABT
11
12
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, MMED EPS is projected to reach 0.153 in FY2027Q2, following reported EPS of 0.000 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q4
FY2027Q1
FY2026Q3
FY2027Q2
FY2027Q3
Forecast
-0.17
0.09
0.16
0.15
0.21
Actual
-1.01
--
--
--
--
Surprise
-491.18%
-100.00%
--
--
--
FAQs
What is MiniMed Ord Shs (Proposed)'s expected revenue for the next quarter?
MiniMed Ord Shs (Proposed)'s expected revenue is 825.29M.
What is MiniMed Ord Shs (Proposed)'s price target?
Analysts forecast that MiniMed Ord Shs (Proposed)'s price target is USD 25.73, with the highest forecast at USD 28.00 and the lowest forecast at USD 21.00.
What is the analyst rating for MiniMed Ord Shs (Proposed)?
Based on the ratings of MiniMed Ord Shs (Proposed)'s stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.